Skip to content

Development of differential markers for benign and malignant lung submandibular nodules based on ctDNA sequencing

Development of differential markers for benign and malignant lung submandibular nodules based on ctDNA sequencing

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024637
Enrollment
Unknown
Registered
2019-07-19
Start date
2019-07-15
Completion date
Unknown
Last updated
2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung submandibular nodules

Interventions

Gold Standard:Pathological diagnosis
Index test:ctDNA sequencing

Sponsors

The Second Affliliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 18-80 year old male or female; high risk factor with at least 1 lung cancer: smoking (more than 1 per day, continuous inhalation for more than 6 months), kitchen fumes, respiratory disease history, history of lung disease (asthma, chronic Obstructive emphysema, pneumonia and tuberculosis), occupational exposure to dust, asbestos dust, indoor pollution (such as decoration workers, indoor coal burning, etc.), pollution sources within 500 meters (smelting, chemical, coking, etc.), family history of lung cancer Women who are pregnant may need to use highly effective methods of contraception (such as oral contraceptives, intrauterine devices, libido or barrier contraceptives combined with spermicides) during the trial; ? Subjects voluntarily join the study Informed consent been signed, with good compliance and follow-up; chest CT showed sub-cm nodules (5mm<d<10mm).

Exclusion criteria

Exclusion criteria: Pregnancy or lactation; abnormal coagulation; HIV-positive; history of psychotropic substance abuse and inability to abstain or history of mental disorder; investigators believe that subjects are not eligible for this study

Design outcomes

Primary

MeasureTime frame
ctDNA;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactShuanying Yang

The Second Affliliated Hospital of Xi'an Jiaotong University

yangshuanying66@163.com+86 13991392919

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026